Global Poliovirus Vaccine Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Poliovirus Vaccine Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Poliovirus Vaccine by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Poliovirus Vaccine by Country/Region, 2017, 2022 & 2028

2.2 Poliovirus Vaccine Segment by Type

2.2.1 Inactivated Polio Vaccine (IPV)

2.2.2 Oral Polio Vaccine (OPV)

2.3 Poliovirus Vaccine Sales by Type

2.3.1 Global Poliovirus Vaccine Sales Market Share by Type (2017-2022)

2.3.2 Global Poliovirus Vaccine Revenue and Market Share by Type (2017-2022)

2.3.3 Global Poliovirus Vaccine Sale Price by Type (2017-2022)

2.4 Poliovirus Vaccine Segment by Application

2.4.1 Public

2.4.2 Private

2.5 Poliovirus Vaccine Sales by Application

2.5.1 Global Poliovirus Vaccine Sale Market Share by Application (2017-2022)

2.5.2 Global Poliovirus Vaccine Revenue and Market Share by Application (2017-2022)

2.5.3 Global Poliovirus Vaccine Sale Price by Application (2017-2022)

3 Global Poliovirus Vaccine by Company

3.1 Global Poliovirus Vaccine Breakdown Data by Company

3.1.1 Global Poliovirus Vaccine Annual Sales by Company (2020-2022)

3.1.2 Global Poliovirus Vaccine Sales Market Share by Company (2020-2022)

3.2 Global Poliovirus Vaccine Annual Revenue by Company (2020-2022)

3.2.1 Global Poliovirus Vaccine Revenue by Company (2020-2022)

3.2.2 Global Poliovirus Vaccine Revenue Market Share by Company (2020-2022)

3.3 Global Poliovirus Vaccine Sale Price by Company

3.4 Key Manufacturers Poliovirus Vaccine Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Poliovirus Vaccine Product Location Distribution

3.4.2 Players Poliovirus Vaccine Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Poliovirus Vaccine by Geographic Region

4.1 World Historic Poliovirus Vaccine Market Size by Geographic Region (2017-2022)

4.1.1 Global Poliovirus Vaccine Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Poliovirus Vaccine Annual Revenue by Geographic Region

4.2 World Historic Poliovirus Vaccine Market Size by Country/Region (2017-2022)

4.2.1 Global Poliovirus Vaccine Annual Sales by Country/Region (2017-2022)

4.2.2 Global Poliovirus Vaccine Annual Revenue by Country/Region

4.3 Americas Poliovirus Vaccine Sales Growth

4.4 APAC Poliovirus Vaccine Sales Growth

4.5 Europe Poliovirus Vaccine Sales Growth

4.6 Middle East & Africa Poliovirus Vaccine Sales Growth

5 Americas

5.1 Americas Poliovirus Vaccine Sales by Country

5.1.1 Americas Poliovirus Vaccine Sales by Country (2017-2022)

5.1.2 Americas Poliovirus Vaccine Revenue by Country (2017-2022)

5.2 Americas Poliovirus Vaccine Sales by Type

5.3 Americas Poliovirus Vaccine Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Poliovirus Vaccine Sales by Region

6.1.1 APAC Poliovirus Vaccine Sales by Region (2017-2022)

6.1.2 APAC Poliovirus Vaccine Revenue by Region (2017-2022)

6.2 APAC Poliovirus Vaccine Sales by Type

6.3 APAC Poliovirus Vaccine Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Poliovirus Vaccine by Country

7.1.1 Europe Poliovirus Vaccine Sales by Country (2017-2022)

7.1.2 Europe Poliovirus Vaccine Revenue by Country (2017-2022)

7.2 Europe Poliovirus Vaccine Sales by Type

7.3 Europe Poliovirus Vaccine Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Poliovirus Vaccine by Country

8.1.1 Middle East & Africa Poliovirus Vaccine Sales by Country (2017-2022)

8.1.2 Middle East & Africa Poliovirus Vaccine Revenue by Country (2017-2022)

8.2 Middle East & Africa Poliovirus Vaccine Sales by Type

8.3 Middle East & Africa Poliovirus Vaccine Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Poliovirus Vaccine

10.3 Manufacturing Process Analysis of Poliovirus Vaccine

10.4 Industry Chain Structure of Poliovirus Vaccine

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Poliovirus Vaccine Distributors

11.3 Poliovirus Vaccine Customer

12 World Forecast Review for Poliovirus Vaccine by Geographic Region

12.1 Global Poliovirus Vaccine Market Size Forecast by Region

12.1.1 Global Poliovirus Vaccine Forecast by Region (2023-2028)

12.1.2 Global Poliovirus Vaccine Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Poliovirus Vaccine Forecast by Type

12.7 Global Poliovirus Vaccine Forecast by Application

13 Key Players Analysis

13.1 Sanofi

13.1.1 Sanofi Company Information

13.1.2 Sanofi Poliovirus Vaccine Product Offered

13.1.3 Sanofi Poliovirus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Sanofi Main Business Overview

13.1.5 Sanofi Latest Developments

13.2 GSK

13.2.1 GSK Company Information

13.2.2 GSK Poliovirus Vaccine Product Offered

13.2.3 GSK Poliovirus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 GSK Main Business Overview

13.2.5 GSK Latest Developments

13.3 Bibcol

13.3.1 Bibcol Company Information

13.3.2 Bibcol Poliovirus Vaccine Product Offered

13.3.3 Bibcol Poliovirus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Bibcol Main Business Overview

13.3.5 Bibcol Latest Developments

13.4 Serum Institute

13.4.1 Serum Institute Company Information

13.4.2 Serum Institute Poliovirus Vaccine Product Offered

13.4.3 Serum Institute Poliovirus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Serum Institute Main Business Overview

13.4.5 Serum Institute Latest Developments

13.5 Tiantan Biological

13.5.1 Tiantan Biological Company Information

13.5.2 Tiantan Biological Poliovirus Vaccine Product Offered

13.5.3 Tiantan Biological Poliovirus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Tiantan Biological Main Business Overview

13.5.5 Tiantan Biological Latest Developments

13.6 IMBCA

13.6.1 IMBCA Company Information

13.6.2 IMBCA Poliovirus Vaccine Product Offered

13.6.3 IMBCA Poliovirus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 IMBCA Main Business Overview

13.6.5 IMBCA Latest Developments

13.7 Panacea Biotec Ltd

13.7.1 Panacea Biotec Ltd Company Information

13.7.2 Panacea Biotec Ltd Poliovirus Vaccine Product Offered

13.7.3 Panacea Biotec Ltd Poliovirus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Panacea Biotec Ltd Main Business Overview

13.7.5 Panacea Biotec Ltd Latest Developments

13.8 Bio-Med

13.8.1 Bio-Med Company Information

13.8.2 Bio-Med Poliovirus Vaccine Product Offered

13.8.3 Bio-Med Poliovirus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Bio-Med Main Business Overview

13.8.5 Bio-Med Latest Developments

13.9 Halfkin Bio-Pharmaceuticals

13.9.1 Halfkin Bio-Pharmaceuticals Company Information

13.9.2 Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Product Offered

13.9.3 Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Halfkin Bio-Pharmaceuticals Main Business Overview

13.9.5 Halfkin Bio-Pharmaceuticals Latest Developments

14 Research Findings and Conclusion

Table 1. Poliovirus Vaccine Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Poliovirus Vaccine Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Inactivated Polio Vaccine (IPV)

Table 4. Major Players of Oral Polio Vaccine (OPV)

Table 5. Global Poliovirus Vaccine Sales by Type (2017-2022) & (K Units)

Table 6. Global Poliovirus Vaccine Sales Market Share by Type (2017-2022)

Table 7. Global Poliovirus Vaccine Revenue by Type (2017-2022) & ($ million)

Table 8. Global Poliovirus Vaccine Revenue Market Share by Type (2017-2022)

Table 9. Global Poliovirus Vaccine Sale Price by Type (2017-2022) & (USD/Unit)

Table 10. Global Poliovirus Vaccine Sales by Application (2017-2022) & (K Units)

Table 11. Global Poliovirus Vaccine Sales Market Share by Application (2017-2022)

Table 12. Global Poliovirus Vaccine Revenue by Application (2017-2022)

Table 13. Global Poliovirus Vaccine Revenue Market Share by Application (2017-2022)

Table 14. Global Poliovirus Vaccine Sale Price by Application (2017-2022) & (USD/Unit)

Table 15. Global Poliovirus Vaccine Sales by Company (2020-2022) & (K Units)

Table 16. Global Poliovirus Vaccine Sales Market Share by Company (2020-2022)

Table 17. Global Poliovirus Vaccine Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Poliovirus Vaccine Revenue Market Share by Company (2020-2022)

Table 19. Global Poliovirus Vaccine Sale Price by Company (2020-2022) & (USD/Unit)

Table 20. Key Manufacturers Poliovirus Vaccine Producing Area Distribution and Sales Area

Table 21. Players Poliovirus Vaccine Products Offered

Table 22. Poliovirus Vaccine Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Poliovirus Vaccine Sales by Geographic Region (2017-2022) & (K Units)

Table 26. Global Poliovirus Vaccine Sales Market Share Geographic Region (2017-2022)

Table 27. Global Poliovirus Vaccine Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Poliovirus Vaccine Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Poliovirus Vaccine Sales by Country/Region (2017-2022) & (K Units)

Table 30. Global Poliovirus Vaccine Sales Market Share by Country/Region (2017-2022)

Table 31. Global Poliovirus Vaccine Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Poliovirus Vaccine Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Poliovirus Vaccine Sales by Country (2017-2022) & (K Units)

Table 34. Americas Poliovirus Vaccine Sales Market Share by Country (2017-2022)

Table 35. Americas Poliovirus Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Poliovirus Vaccine Revenue Market Share by Country (2017-2022)

Table 37. Americas Poliovirus Vaccine Sales by Type (2017-2022) & (K Units)

Table 38. Americas Poliovirus Vaccine Sales Market Share by Type (2017-2022)

Table 39. Americas Poliovirus Vaccine Sales by Application (2017-2022) & (K Units)

Table 40. Americas Poliovirus Vaccine Sales Market Share by Application (2017-2022)

Table 41. APAC Poliovirus Vaccine Sales by Region (2017-2022) & (K Units)

Table 42. APAC Poliovirus Vaccine Sales Market Share by Region (2017-2022)

Table 43. APAC Poliovirus Vaccine Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Poliovirus Vaccine Revenue Market Share by Region (2017-2022)

Table 45. APAC Poliovirus Vaccine Sales by Type (2017-2022) & (K Units)

Table 46. APAC Poliovirus Vaccine Sales Market Share by Type (2017-2022)

Table 47. APAC Poliovirus Vaccine Sales by Application (2017-2022) & (K Units)

Table 48. APAC Poliovirus Vaccine Sales Market Share by Application (2017-2022)

Table 49. Europe Poliovirus Vaccine Sales by Country (2017-2022) & (K Units)

Table 50. Europe Poliovirus Vaccine Sales Market Share by Country (2017-2022)

Table 51. Europe Poliovirus Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Poliovirus Vaccine Revenue Market Share by Country (2017-2022)

Table 53. Europe Poliovirus Vaccine Sales by Type (2017-2022) & (K Units)

Table 54. Europe Poliovirus Vaccine Sales Market Share by Type (2017-2022)

Table 55. Europe Poliovirus Vaccine Sales by Application (2017-2022) & (K Units)

Table 56. Europe Poliovirus Vaccine Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Poliovirus Vaccine Sales by Country (2017-2022) & (K Units)

Table 58. Middle East & Africa Poliovirus Vaccine Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Poliovirus Vaccine Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Poliovirus Vaccine Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Poliovirus Vaccine Sales by Type (2017-2022) & (K Units)

Table 62. Middle East & Africa Poliovirus Vaccine Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Poliovirus Vaccine Sales by Application (2017-2022) & (K Units)

Table 64. Middle East & Africa Poliovirus Vaccine Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Poliovirus Vaccine

Table 66. Key Market Challenges & Risks of Poliovirus Vaccine

Table 67. Key Industry Trends of Poliovirus Vaccine

Table 68. Poliovirus Vaccine Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Poliovirus Vaccine Distributors List

Table 71. Poliovirus Vaccine Customer List

Table 72. Global Poliovirus Vaccine Sales Forecast by Region (2023-2028) & (K Units)

Table 73. Global Poliovirus Vaccine Sales Market Forecast by Region

Table 74. Global Poliovirus Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Poliovirus Vaccine Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Poliovirus Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 77. Americas Poliovirus Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Poliovirus Vaccine Sales Forecast by Region (2023-2028) & (K Units)

Table 79. APAC Poliovirus Vaccine Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Poliovirus Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Europe Poliovirus Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Poliovirus Vaccine Sales Forecast by Country (2023-2028) & (K Units)

Table 83. Middle East & Africa Poliovirus Vaccine Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Poliovirus Vaccine Sales Forecast by Type (2023-2028) & (K Units)

Table 85. Global Poliovirus Vaccine Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Poliovirus Vaccine Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Poliovirus Vaccine Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Poliovirus Vaccine Sales Forecast by Application (2023-2028) & (K Units)

Table 89. Global Poliovirus Vaccine Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Poliovirus Vaccine Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Poliovirus Vaccine Revenue Market Share Forecast by Application (2023-2028)

Table 92. Sanofi Basic Information, Poliovirus Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 93. Sanofi Poliovirus Vaccine Product Offered

Table 94. Sanofi Poliovirus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 95. Sanofi Main Business

Table 96. Sanofi Latest Developments

Table 97. GSK Basic Information, Poliovirus Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 98. GSK Poliovirus Vaccine Product Offered

Table 99. GSK Poliovirus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 100. GSK Main Business

Table 101. GSK Latest Developments

Table 102. Bibcol Basic Information, Poliovirus Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 103. Bibcol Poliovirus Vaccine Product Offered

Table 104. Bibcol Poliovirus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 105. Bibcol Main Business

Table 106. Bibcol Latest Developments

Table 107. Serum Institute Basic Information, Poliovirus Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 108. Serum Institute Poliovirus Vaccine Product Offered

Table 109. Serum Institute Poliovirus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 110. Serum Institute Main Business

Table 111. Serum Institute Latest Developments

Table 112. Tiantan Biological Basic Information, Poliovirus Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 113. Tiantan Biological Poliovirus Vaccine Product Offered

Table 114. Tiantan Biological Poliovirus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 115. Tiantan Biological Main Business

Table 116. Tiantan Biological Latest Developments

Table 117. IMBCA Basic Information, Poliovirus Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 118. IMBCA Poliovirus Vaccine Product Offered

Table 119. IMBCA Poliovirus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 120. IMBCA Main Business

Table 121. IMBCA Latest Developments

Table 122. Panacea Biotec Ltd Basic Information, Poliovirus Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 123. Panacea Biotec Ltd Poliovirus Vaccine Product Offered

Table 124. Panacea Biotec Ltd Poliovirus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 125. Panacea Biotec Ltd Main Business

Table 126. Panacea Biotec Ltd Latest Developments

Table 127. Bio-Med Basic Information, Poliovirus Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 128. Bio-Med Poliovirus Vaccine Product Offered

Table 129. Bio-Med Poliovirus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 130. Bio-Med Main Business

Table 131. Bio-Med Latest Developments

Table 132. Halfkin Bio-Pharmaceuticals Basic Information, Poliovirus Vaccine Manufacturing Base, Sales Area and Its Competitors

Table 133. Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Product Offered

Table 134. Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 135. Halfkin Bio-Pharmaceuticals Main Business

Table 136. Halfkin Bio-Pharmaceuticals Latest Developments

List of Figures

Figure 1. Picture of Poliovirus Vaccine

Figure 2. Poliovirus Vaccine Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Poliovirus Vaccine Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Poliovirus Vaccine Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Poliovirus Vaccine Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Inactivated Polio Vaccine (IPV)

Figure 10. Product Picture of Oral Polio Vaccine (OPV)

Figure 11. Global Poliovirus Vaccine Sales Market Share by Type in 2021

Figure 12. Global Poliovirus Vaccine Revenue Market Share by Type (2017-2022)

Figure 13. Poliovirus Vaccine Consumed in Public

Figure 14. Global Poliovirus Vaccine Market: Public (2017-2022) & (K Units)

Figure 15. Poliovirus Vaccine Consumed in Private

Figure 16. Global Poliovirus Vaccine Market: Private (2017-2022) & (K Units)

Figure 17. Global Poliovirus Vaccine Sales Market Share by Application (2017-2022)

Figure 18. Global Poliovirus Vaccine Revenue Market Share by Application in 2021

Figure 19. Poliovirus Vaccine Revenue Market by Company in 2021 ($ Million)

Figure 20. Global Poliovirus Vaccine Revenue Market Share by Company in 2021

Figure 21. Global Poliovirus Vaccine Sales Market Share by Geographic Region (2017-2022)

Figure 22. Global Poliovirus Vaccine Revenue Market Share by Geographic Region in 2021

Figure 23. Global Poliovirus Vaccine Sales Market Share by Region (2017-2022)

Figure 24. Global Poliovirus Vaccine Revenue Market Share by Country/Region in 2021

Figure 25. Americas Poliovirus Vaccine Sales 2017-2022 (K Units)

Figure 26. Americas Poliovirus Vaccine Revenue 2017-2022 ($ Millions)

Figure 27. APAC Poliovirus Vaccine Sales 2017-2022 (K Units)

Figure 28. APAC Poliovirus Vaccine Revenue 2017-2022 ($ Millions)

Figure 29. Europe Poliovirus Vaccine Sales 2017-2022 (K Units)

Figure 30. Europe Poliovirus Vaccine Revenue 2017-2022 ($ Millions)

Figure 31. Middle East & Africa Poliovirus Vaccine Sales 2017-2022 (K Units)

Figure 32. Middle East & Africa Poliovirus Vaccine Revenue 2017-2022 ($ Millions)

Figure 33. Americas Poliovirus Vaccine Sales Market Share by Country in 2021

Figure 34. Americas Poliovirus Vaccine Revenue Market Share by Country in 2021

Figure 35. United States Poliovirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 36. Canada Poliovirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 37. Mexico Poliovirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 38. Brazil Poliovirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 39. APAC Poliovirus Vaccine Sales Market Share by Region in 2021

Figure 40. APAC Poliovirus Vaccine Revenue Market Share by Regions in 2021

Figure 41. China Poliovirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 42. Japan Poliovirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 43. South Korea Poliovirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 44. Southeast Asia Poliovirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 45. India Poliovirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 46. Australia Poliovirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 47. Europe Poliovirus Vaccine Sales Market Share by Country in 2021

Figure 48. Europe Poliovirus Vaccine Revenue Market Share by Country in 2021

Figure 49. Germany Poliovirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 50. France Poliovirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 51. UK Poliovirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 52. Italy Poliovirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 53. Russia Poliovirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 54. Middle East & Africa Poliovirus Vaccine Sales Market Share by Country in 2021

Figure 55. Middle East & Africa Poliovirus Vaccine Revenue Market Share by Country in 2021

Figure 56. Egypt Poliovirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 57. South Africa Poliovirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 58. Israel Poliovirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 59. Turkey Poliovirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 60. GCC Country Poliovirus Vaccine Revenue Growth 2017-2022 ($ Millions)

Figure 61. Manufacturing Cost Structure Analysis of Poliovirus Vaccine in 2021

Figure 62. Manufacturing Process Analysis of Poliovirus Vaccine

Figure 63. Industry Chain Structure of Poliovirus Vaccine

Figure 64. Channels of Distribution

Figure 65. Distributors Profiles